文献
J-GLOBAL ID:201702252525759712
整理番号:17A0087698
転移性結腸直腸癌のための第三次もしくはそれ以降の治療としてのオキサリプラチン再導入に関する多施設無作為第2相試験-隔週対標準的週3回のXELOX(ORION研究)
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study)
著者 (15件):
Matsuda Chu
(Osaka General Medical Center)
,
Honda Michitaka
(Gastroenterological Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research)
,
Tanaka Chihiro
(Gifu Prefectural General Medical Center)
,
Fukunaga Mutsumi
(Hyogo Prefectural Nishinomiya Hospital)
,
Ishibashi Keiichiro
(Saitama Medical University)
,
Munemoto Yoshinori
(Fukui Saiseikai Hospital)
,
Hata Taishi
(Osaka University)
,
Bando Hiroyuki
(Ishikawa Prefectural Central Hospital)
,
Oshiro Mitsuru
(Toho University, Sakura Hospital)
,
Kobayashi Michiya
(Kochi Medical School, Kochi University)
,
Tokunaga Yukihiko
(Japan Post Kyoto Teishin Hospital)
,
Fujii Akitomo
(Rinku General Medical Center)
,
Nagata Naoki
(Kitakyushu General Hospital)
,
Oba Koji
(University of Tokyo)
,
Mishima Hideyuki
(Aichi Medical University)
資料名:
International Journal of Clinical Oncology
(International Journal of Clinical Oncology)
巻:
21
号:
3
ページ:
566-572
発行年:
2016年06月
JST資料番号:
L3966A
ISSN:
1341-9625
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)